Landmark Wealth Management (New York)’s AbbVie ABBV Stock Holding History

Landmark Wealth Management (New York)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Buy	+5,447	New	+$1.21M	0.32%	59
2022 Q2	–	Sell	-415	Closed	-$415	–	40
2022 Q1	$415	Buy	+415	New	+$60.3K	﹤0.01%	134

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Landmark Wealth Management (New York)'s ABBV Position: Q1 2026 in Review

Landmark Wealth Management (New York) opened a new position in AbbVie (ABBV) in Q1 2026: 5,447 shares worth $1.18M. The stake represents 0.32% of the portfolio and ranks #59 among its holdings. This is a return to the name: Landmark Wealth Management (New York) previously reported a position in ABBV as recently as Q1 2022.

Landmark Wealth Management (New York) first reported a position in ABBV in Q1 2022 and has held it in 2 quarters since. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Landmark Wealth Management (New York) held 5,447 shares of AbbVie worth $1.18M as of Q1 2026.
AbbVie was a new Landmark Wealth Management (New York) position in Q1 2026.
AbbVie made up 0.32% of Landmark Wealth Management (New York)'s portfolio in Q1 2026, its #59 holding.
Landmark Wealth Management (New York) first reported a position in AbbVie in Q1 2022 and has held it in 2 quarters since.
4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Landmark Wealth Management (New York)'s 13F filing for Q1 2026, filed 29 Apr 2026.